MMP7 and myeloid sarcoma: As MMP7 efficiently degrades CSPGs and fibronectin, both known to inhibit OPC maturation and transiently expressed upon demyelination while being persistent in MS lesions (Lau et al., 2012; Stoffels et al., 2013), MMP7 may aid to their timely degradation.